SEC Form 4 · accession 0001553878-15-000027
ALNYLAM PHARMACEUTICALS, INC. · ALNY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barry E Greene
Officer — President and COO
Period of report
Aug 4, 2015
Accepted (ET)
Aug 6, 2015 · 5:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178670
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 4, 2015 | M | 6,621 | $13.12 | A | 30,013 | D | |
| Common Stock | Aug 4, 2015 | M | 4,395 | $22.75 | A | 34,408 | D | |
| Common Stock | Aug 4, 2015 | M | 3,185 | $31.39 | A | 37,593 | D | |
| Common Stock | Aug 4, 2015 | M | 4,684 | $21.35 | A | 42,277 | D | |
| Common Stock | Aug 4, 2015 | M | 6,087 | $16.43 | A | 48,364 | D | |
| Common Stock | Aug 4, 2015 | M | 2,000 | $9.14 | A | 50,364 | D | |
| Common StockF1 | holding | — | — | — | 2,611 | I | By Managed Account |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $13.12 | Aug 4, 2015 | M | 6,621 | D | — | Dec 7, 2015 | Common Stock | 6,621 | 0 | D |
| Stock Option (Right to Buy)F2 | $22.75 | Aug 4, 2015 | M | 4,395 | D | — | Dec 14, 2016 | Common Stock | 4,395 | 0 | D |
| Stock Option (Right to Buy)F2 | $9.14 | Aug 4, 2015 | M | 2,000 | D | — | Dec 8, 2020 | Common Stock | 2,000 | 98,000 | D |
| Stock Option (Right to Buy)F2 | $16.43 | Aug 4, 2015 | M | 6,087 | D | — | Dec 9, 2019 | Common Stock | 6,087 | 58,913 | D |
| Stock Option (Right to Buy)F2 | $21.35 | Aug 4, 2015 | M | 4,684 | D | — | Dec 8, 2018 | Common Stock | 4,684 | 85,316 | D |
| Stock Option (Right to Buy)F2 | $31.39 | Aug 4, 2015 | M | 3,185 | D | — | Dec 12, 2017 | Common Stock | 3,185 | 76,815 | D |
Explanation of responses
- F1The reporting person owns 2,611 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
- F2The stock option vests as to 25% of the shares on the first anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.